Assignee
FORTIS THERAPEUTICS INC
US·3 granted patents·2 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
5 records- 0168US12144888B2Immunoconjugates targeting CD46 and methods of use thereofFORTIS THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·19 claims
- 0267US2023035087A1Immunoconjugates targeting cd46 and methods of use thereofFORTIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0365US11484604B2Immunoconjugates targeting CD46 and methods of use thereofFORTIS THERAPEUTICS INC·Filed 2021·Granted Nov 1, 2022·0 cites·4 claims
- 0452US2024058464A1Combination therapy with for46 for cancerFORTIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0544US12049511B2Engineered CD46-specific effector cells and uses thereof in the treatment of cancerFORTIS THERAPEUTICS INC·Filed 2017·Granted Jul 30, 2024·0 cites·19 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →